Cargando…
Dose-dependent reversal of KCC2 hypofunction and phenobarbital-resistant neonatal seizures by ANA12
Neonatal seizures have an incidence of 3.5 per 1000 newborns; while hypoxic-ischemic encephalopathy (HIE) accounts for 50–60% of cases, half are resistant to 1st-line anti-seizure drugs such as phenobarbital (PB). Tyrosine receptor kinase B (TrkB) activation following ischemic injury is known to inc...
Autores principales: | Carter, B. M., Sullivan, B. J., Landers, J. R., Kadam, S. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086916/ https://www.ncbi.nlm.nih.gov/pubmed/30097625 http://dx.doi.org/10.1038/s41598-018-30486-7 |
Ejemplares similares
-
Ganaxolone versus Phenobarbital for Neonatal Seizure Management
por: Miller, Suzanne L., et al.
Publicado: (2022) -
Age- and sex-dependent susceptibility to phenobarbital-resistant neonatal seizures: role of chloride co-transporters
por: Kang, Seok Kyu, et al.
Publicado: (2015) -
Mild KCC2 Hypofunction Causes Inconspicuous Chloride Dysregulation that Degrades Neural Coding
por: Doyon, Nicolas, et al.
Publicado: (2016) -
Phenobarbital reduces EEG amplitude and propagation of neonatal seizures but does not alter performance of automated seizure detection
por: Mathieson, Sean R., et al.
Publicado: (2016) -
Complex spectrum of phenobarbital effects in a mouse model of neonatal hypoxia-induced seizures
por: Quinlan, Sean M. M., et al.
Publicado: (2018)